$10.97 B
Share price
Change (1 day)
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) Fails to deliver data

Key failure to deliver metrics for Bio-Techne:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Bio-Techne (TECH) - 3 month history

Number of shares, 3 month chart

Biweekly Failures to deliver volume for Bio-Techne (TECH) - since 2014

Volume in USD (price x number of shares), data since 2014

Bio-Techne (TECH) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2023$31.22 M-38.39%
2022$50.68 M-42.56%
2021$88.22 M200.19%
2020$29.39 M124.27%
2019$13.1 M90.7%
2018$6.87 M-5.05%
2017$7.23 M-54.94%
2016$16.06 M17.78%
2015$13.63 M342.13%
2014$3.08 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$49.97 M$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
$50.54 M$88.16 M๐Ÿ‡บ๐Ÿ‡ธ USA
$40.43 M$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
$76.42 M$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
$20.92 M$53.25 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.44 M$1 M๐Ÿ‡บ๐Ÿ‡ธ USA
$1.72 M$14.8 M๐Ÿ‡บ๐Ÿ‡ธ USA